In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other best healthcare stocks to buy according to hedge funds. Resilience and Growth in the U.S.

Merck & Co. has picked up options on two Evaxion Biotech vaccine candidates, paying $3.2 million and dangling more than $1 billion in milestones for the chance to pick up preclinical prospects ...

Merck is immune from an antitrust lawsuit accusing it of misleading regulators about the effectiveness of its mumps vaccine ...

is scheduled to review both the two new vaccines and decide how they should be used in adults, according to Merck. Prevnar 20 has now been launched at a list price of $232, roughly in line with ...

A class-action lawsuit claims Merck overcharged for a less potent mumps vaccine, violating the Sherman Act. The District Court denied Merck's summary judgment, acknowledging ethical issues but ...

Merck & Co. escaped antitrust claims by a group physicians who alleged that they bought the company’s mumps vaccine at inflated prices because it deceived the government to maintain its monopoly on ...

Merck's P/S multiple is roughly 4, and its P/FCF is 21. That makes its valuation a bit pricier than Pfizer's per dollar of revenue, but significantly cheaper per dollar of free cash flow. In other ...

RAHWAY, N.J. - Merck Animal Health, a division of Merck & Co., Inc. (NYSE:MRK), has announced the release of a new vaccine, NOBIVAC NXT FeLV, to protect cats against feline leukemia virus (FeLV).

Merck (NYSE: MRK), known as MSD outside of the ... the continued impact of its increasingly broad and diverse vaccines and infectious disease portfolio and the potential of its innovative pipeline ...

2024--New Data to be Presented at IDWeek 2024 Reinforce Merck’s Broad and Diverse Vaccines and Infectious Disease Pipeline and Portfolio We recently compiled a list titled 7 Best Cheap Stocks to ...

We recently published a list of 10 Best Healthcare ... and sells prescription medicines, vaccines, and animal health products. At its core, Merck is in the business of improving human and animal ...